Abstract | BACKGROUND: Many studies have revealed that mucosal healing improves the long-term prognosis of ulcerative colitis. Frequent colonoscopy is difficult because of its invasiveness and cost. Therefore, in diagnosing and treating ulcerative colitis, noninvasive, low-cost methods for predicting mucosal healing using useful biomarkers are required in the clinical setting. This study aimed to evaluate whether serum amyloid A is a better serum biomarker than C-reactive protein in predicting mucosal healing in ulcerative colitis patients in clinical remission. METHODS: RESULTS: CONCLUSIONS:
|
Authors | Masaki Wakai, Ryohei Hayashi, Shinji Tanaka, Toshikatsu Naito, Junko Kumada, Motonobu Nomura, Hidehiko Takigawa, Shiro Oka, Yoshitaka Ueno, Masanori Ito, Kazuaki Chayama |
Journal | BMC gastroenterology
(BMC Gastroenterol)
Vol. 20
Issue 1
Pg. 85
(Apr 03 2020)
ISSN: 1471-230X [Electronic] England |
PMID | 32245401
(Publication Type: Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Anti-Inflammatory Agents, Non-Steroidal
- Biological Products
- Biomarkers
- Immunologic Factors
- Serum Amyloid A Protein
- Mesalamine
- C-Reactive Protein
|
Topics |
- Adolescent
- Adrenal Cortex Hormones
(therapeutic use)
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Biological Products
(therapeutic use)
- Biomarkers
(metabolism)
- C-Reactive Protein
(metabolism)
- Child
- Colitis, Ulcerative
(drug therapy, metabolism, pathology)
- Colonoscopy
- Female
- Humans
- Immunologic Factors
(therapeutic use)
- Intestinal Mucosa
(pathology)
- Male
- Mesalamine
(therapeutic use)
- Middle Aged
- Remission Induction
- Serum Amyloid A Protein
(metabolism)
- Severity of Illness Index
- Young Adult
|